{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:46:02Z","timestamp":1768405562406,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bja.2023.12.008","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T05:38:25Z","timestamp":1707543505000},"page":"466-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Danavorexton (TAK-925): an orexin receptor 2 agonist as a new \u2018arousal\u2019 agent"],"prefix":"10.1016","volume":"132","author":[{"given":"David G.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2023.12.008_bib1","first-page":"2021","article-title":"Orexin receptors in GtoPdb v.2021.3","author":"Coleman","year":"2021","journal-title":"IUPHAR BPS Guide Pharm CITE"},{"key":"10.1016\/j.bja.2023.12.008_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.812359","article-title":"Orexin signaling: a complex, multifaceted process","volume":"16","author":"Dale","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.bja.2023.12.008_bib3","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1038\/s41467-023-38764-3","article-title":"The G protein preference of orexin receptors is currently an unresolved issue","volume":"14","author":"Kukkonen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.bja.2023.12.008_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-pharmtox-010510-100528","article-title":"Orexin receptors: pharmacology and therapeutic opportunities","volume":"51","author":"Scammell","year":"2011","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bja.2023.12.008_bib5","article-title":"Physiological role of orexin\/hypocretin in the human body in motivated behavior: a comprehensive review","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bja.2023.12.008_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bja.2023.12.032","article-title":"Effects of the orexin receptor 2 agonist danavorexton on emergence from general anaesthesia and opioid-induced sedation, respiratory depression and analgesia in rats and monkeys","volume":"132","author":"Suzuki","year":"2024","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2023.12.008_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13665","article-title":"The orexin story, sleep and sleep disturbances","volume":"31","author":"Pizza","year":"2022","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.bja.2023.12.008_bib8","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1073\/pnas.1700499114","article-title":"Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models","volume":"114","author":"Irukayama-Tomobe","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bja.2023.12.008_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104179","article-title":"From orexin receptor agonist YNT-185 to novel antagonists with drug-like properties for the treatment of insomnia","volume":"103","author":"Mezeiova","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bja.2023.12.008_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/cmdc.201300003","article-title":"Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonist","volume":"8","author":"Steiner","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bja.2023.12.008_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/jpet.109.152009","article-title":"Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the rat","volume":"330","author":"Dugovic","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.bja.2023.12.008_bib12","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1016\/j.bmcl.2004.06.032","article-title":"Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX2R) antagonists","volume":"14","author":"McAtee","year":"2004","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bja.2023.12.008_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13902","article-title":"The orexin story and orexin receptor antagonists for the treatment of insomnia","volume":"32","author":"Muehlan","year":"2023","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.bja.2023.12.008_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2019.172794","article-title":"TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice","volume":"187","author":"Yukitake","year":"2019","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bja.2023.12.008_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13878","article-title":"Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals","volume":"32","author":"Evans","year":"2023","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.bja.2023.12.008_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/EJA.0000000000001876","article-title":"Update of the European Society of Anaesthesiology and Intensive Care Medicine evidence-based and consensus-based guideline on postoperative delirium in adult patients","author":"Aldecoa","year":"2023","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.bja.2023.12.008_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2147\/LRA.S230728","article-title":"Delayed emergence from anesthesia: what we know and how we act","volume":"13","author":"Cascella","year":"2020","journal-title":"Local Reg Anesth"},{"key":"10.1016\/j.bja.2023.12.008_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bja.2021.07.021","article-title":"Anaesthetic depth and delirium after major surgery: a randomised clinical trial","volume":"127","author":"Evered","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2023.12.008_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.bja.2021.02.030","article-title":"Surgery and opioids: evidence-based expert consensus guidelines on the perioperative use of opioids in the United Kingdom","volume":"126","author":"Srivastava","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bja.2023.12.008_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2008.10.041","article-title":"Interaction between orexinergic neurons and NMDA receptors in the control of locus coeruleus-cerebrocortical noradrenergic activity of the rat","volume":"1250","author":"Tose","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.bja.2023.12.008_bib21","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1152\/ajpregu.00831.2005","article-title":"NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL\/6J mice","volume":"291","author":"Bryant","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bja.2023.12.008_bib22","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(19)30430-1","article-title":"Perioperative opioid analgesia\u2014when is enough too much? A review of opioid-induced tolerance and hyperalgesia","volume":"393","author":"Colvin","year":"2019","journal-title":"Lancet"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091223007055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091223007055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T01:52:17Z","timestamp":1740793937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091223007055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0007091223007055"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2023.12.008","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danavorexton (TAK-925): an orexin receptor 2 agonist as a new \u2018arousal\u2019 agent","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2023.12.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}